What are the differences between Low Level Laser Therapy (LLLT) devices and Light Emitting Diode (LED) based devices used for Photodynamic Therapy (PDT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

LLLT Devices vs LED-Based Devices for Photodynamic Therapy

Both Low-Level Laser Therapy (LLLT) devices and Light-Emitting Diode (LED) devices are used for Photodynamic Therapy (PDT), with laser-based systems being preferred for PDT due to their precise wavelength delivery and stable beam characteristics, while LED devices offer advantages of portability, lower cost, and suitability for treating larger areas. 1

LLLT (Laser) Devices Used for PDT

Laser Types

  • Semiconductor/Diode Lasers:

    • Wavelength range: 600-950 nm
    • Examples: Specific models include those emitting at 630 ± 5 nm 1
    • Features: Portable, deliver monochromatic light via optical fiber 1
  • Argon Lasers:

    • Wavelength range: 448-514.5 nm
    • Features: Require laser safety protocols 1
  • Solid-State Lasers:

    • Nd:YAG lasers: 1064,532,355, or 266 nm
    • Features: Highly precise, stable beam 1
  • Other Laser Types:

    • Copper vapor dye lasers (630 nm)
    • Argon dye lasers (630 nm)
    • Nd:YAG-KTP dye lasers (630 nm) 1

Advantages of Laser Devices

  • Deliver monochromatic light at specific wavelengths
  • Provide stable beam characteristics
  • Allow precise light dosimetry calculations
  • Enable optimal wavelength matching to specific photosensitizers
  • Better tissue penetration at specific wavelengths 1

LED-Based Devices Used for PDT

LED Types

  • High-Power LED Arrays:

    • Wavelength range: 350-1100 nm
    • Examples: PRP 100 (630 ± 5 nm) 1
    • Features: Portable, relatively inexpensive, narrow spectral emission 1
  • Fluorescent Lamps:

    • Example: DUSA Blu-U (417 ± 5 nm)
    • Features: Large treatment area (>20 cm), used primarily for AKs 1
  • Other Light Sources:

    • Xenon arc lamps (e.g., Paterson PTL, 630 ± 15 nm)
    • Metal halide lamps (e.g., Waldmann 1200,600-750 nm)
    • Tungsten/halogen lamps (570-1100 nm) 1

Advantages of LED Devices

  • Lower cost than laser systems
  • Virtually maintenance-free
  • Portable options available
  • Suitable for treating larger areas
  • Less complex setup and operation 1

Which Devices Are Used for PDT?

Primary PDT Applications

  1. Dermatological Conditions:

    • Both LLLT and LED devices are used for:
      • Actinic keratosis (AK)
      • Basal cell carcinoma (BCC)
      • Squamous cell carcinoma in situ (Bowen's disease)
      • Skin rejuvenation 2
  2. Oral Applications:

    • Laser devices are preferred for oral leukoplakia due to precise delivery via optical fibers 1
  3. Device Selection Based on Condition:

    • For AKs: Both LED arrays (red light) and fluorescent lamps (blue light) are commonly used 1
    • For BCC/SCC in situ: Red light sources (630 nm) from either lasers or LEDs are preferred for deeper penetration 1
    • For skin rejuvenation: Both conventional PDT (c-PDT) and daylight PDT (DL-PDT) using various light sources 2

Photosensitizers Used with These Devices

  • 5-Aminolevulinic acid (5-ALA): Used with both LLLT and LED devices
  • Methyl aminolevulinate (MAL): Standard procedures involve LED light sources
  • Other photosensitizers: Hypericin, phthalocyanine, benzoporphyrin derivatives 1

Key Differences and Clinical Considerations

Wavelength and Penetration

  • Therapeutic Window: 600-800 nm is optimal for PDT (the "therapeutic window") 1
  • Penetration Depth:
    • Red light (630 nm): 1-3 mm penetration in skin, suitable for deeper lesions
    • Blue light (410-450 nm): Less penetrating, suitable for superficial lesions 1

Treatment Parameters

  • Fluence Rate: Should be kept below 50 mW/cm² to maintain oxygen availability
  • Fluence: Typically 37-75 J/cm² for red light, with higher doses potentially increasing treatment depth 1

Treatment Efficacy

  • Studies show comparable efficacy between laser and LED devices for conditions like acne vulgaris 3
  • Pain scores are often higher with certain light sources, with blue laser PDT showing more severe adverse effects than red LED PDT 3

Clinical Pitfalls and Considerations

  1. Avoid excessive fluence rates (>400 mW/cm²) which can cause hyperthermic injury 1

  2. Consider tissue penetration needs when selecting wavelength:

    • Use red light (630 nm) for deeper lesions like BCC
    • Blue light (410-450 nm) may be sufficient for superficial lesions like AKs 1
  3. Be aware of device limitations:

    • Commercial PDT light sources may not deliver uniform doses across the treatment field 1
    • Light dose can fall to just over one-third at only 2 cm from the central area 1
  4. Pain management:

    • LED-PDT often causes more pain than daylight PDT
    • Red LED-PDT typically causes less pain than blue laser PDT 4, 3
  5. Treatment protocols vary:

    • AK typically requires one treatment
    • BCC and SCC in situ typically require two treatments 7 days apart 1

By understanding the differences between LLLT and LED-based devices for PDT, clinicians can select the most appropriate technology based on the specific condition, required penetration depth, and practical considerations such as cost and portability.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Photodynamic therapy for aesthetic-cosmetic indications.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.